FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2890922031> ?p ?o ?g. }

• W2890922031 abstract "Abstract Background Survival for esophageal cancer remains poor despite neo-adjuvant chemo-radiotherapy (nCRT) and surgical resection. The median survival for nCRT plus surgery in the CROSS trial was 48 months with a pathological complete response (pCR) rate of 29%. All pCR patients will have been clinical complete responders (cCR) and while surveillance and salvage surgery (S + SS) for cCR in rectal cancer is well investigated, it is unclear whether the outcomes are similar in esophageal cancer. As morbidity and mortality following esophagectomy is high, avoidance of surgery for predicted pCR would represent a clear advantage. Our unit offers a supported choice for cCR patients to opt for surgery or for surveillance. There is currently no literature on the cost benefit of a watch and wait policy for esophageal cancer patients with a complete clinical response. Methods We identified all cCR patients from a prospectively collected database of esophageal cancer patients offered curative treatment with nCRT from 1999 to 2017. We costed the S + SS group for whom accurate costing data was available and we matched these, according to time of follow up, to a control group of cCR who underwent surgery. Cost (from the National DRG cost manual) was calculated based on cost of surgery, ICU stay, admission length, and follow up radiological and endoscopic procedures. The data was analysed using a two-tailed, equal variance t-test. Results Of 237 patients who received nCRT, 86 had a cCR. Of these, 15 patients in the S + SS fulfilled the selection criteria with a mean follow up of 10.2 compared with 10.4 months in the control group (P = 0.925). The mean number of days in hospital was 19.2 vs. 43.2 days consecutively during the follow up period. The mean estimated cost to the HSE was €91,480 for S + SS compared with €301,280 for the controlled surgery group (P = 0.01). Conclusion This study identified a significant cost benefit for surveillance over surgery. Further studies are required to accurately identify those who cannot benefit from surgery and to assess quality of life years gained and cost per year of life are needed. Disclosure All authors have declared no conflicts of interest." @default.
• W2890922031 created "2018-09-27" @default.
• W2890922031 creator A5005506822 @default.
• W2890922031 creator A5065219557 @default.
• W2890922031 creator A5067731794 @default.
• W2890922031 date "2018-09-01" @default.
• W2890922031 modified "2023-09-27" @default.
• W2890922031 title "FA03.06: THE COST BENEFIT OF A WATCH AND WAIT POLICY FOR COMPLETE CLINICAL RESPONDERS FOLLOWING NEO-ADJUVANT THERAPY IN ESOPHAGEAL CANCER" @default.
• W2890922031 doi "https://doi.org/10.1093/dote/doy089.fa03.06" @default.
• W2890922031 hasPublicationYear "2018" @default.
• W2890922031 type Work @default.
• W2890922031 sameAs 2890922031 @default.
• W2890922031 citedByCount "0" @default.
• W2890922031 crossrefType "journal-article" @default.
• W2890922031 hasAuthorship W2890922031A5005506822 @default.
• W2890922031 hasAuthorship W2890922031A5065219557 @default.
• W2890922031 hasAuthorship W2890922031A5067731794 @default.
• W2890922031 hasConcept C121608353 @default.
• W2890922031 hasConcept C126322002 @default.
• W2890922031 hasConcept C143998085 @default.
• W2890922031 hasConcept C177713679 @default.
• W2890922031 hasConcept C2777863537 @default.
• W2890922031 hasConcept C2777982462 @default.
• W2890922031 hasConcept C2779742542 @default.
• W2890922031 hasConcept C61434518 @default.
• W2890922031 hasConcept C71924100 @default.
• W2890922031 hasConceptScore W2890922031C121608353 @default.
• W2890922031 hasConceptScore W2890922031C126322002 @default.
• W2890922031 hasConceptScore W2890922031C143998085 @default.
• W2890922031 hasConceptScore W2890922031C177713679 @default.
• W2890922031 hasConceptScore W2890922031C2777863537 @default.
• W2890922031 hasConceptScore W2890922031C2777982462 @default.
• W2890922031 hasConceptScore W2890922031C2779742542 @default.
• W2890922031 hasConceptScore W2890922031C61434518 @default.
• W2890922031 hasConceptScore W2890922031C71924100 @default.
• W2890922031 hasLocation W28909220311 @default.
• W2890922031 hasOpenAccess W2890922031 @default.
• W2890922031 hasPrimaryLocation W28909220311 @default.
• W2890922031 hasRelatedWork W121210528 @default.
• W2890922031 hasRelatedWork W2027084062 @default.
• W2890922031 hasRelatedWork W2032022811 @default.
• W2890922031 hasRelatedWork W2044924505 @default.
• W2890922031 hasRelatedWork W2045767143 @default.
• W2890922031 hasRelatedWork W2084932287 @default.
• W2890922031 hasRelatedWork W2100928839 @default.
• W2890922031 hasRelatedWork W2121667579 @default.
• W2890922031 hasRelatedWork W2246982801 @default.
• W2890922031 hasRelatedWork W2418037275 @default.
• W2890922031 hasRelatedWork W2429982913 @default.
• W2890922031 hasRelatedWork W2890757009 @default.
• W2890922031 hasRelatedWork W2953005757 @default.
• W2890922031 hasRelatedWork W2972423818 @default.
• W2890922031 hasRelatedWork W2978907966 @default.
• W2890922031 hasRelatedWork W2979078371 @default.
• W2890922031 hasRelatedWork W384464223 @default.
• W2890922031 hasRelatedWork W2087788457 @default.
• W2890922031 hasRelatedWork W2500924888 @default.
• W2890922031 hasRelatedWork W2737516583 @default.
• W2890922031 isParatext "false" @default.
• W2890922031 isRetracted "false" @default.
• W2890922031 magId "2890922031" @default.
• W2890922031 workType "article" @default.